Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Angleterre1115
P. Jenner15
Angleterre Sauf P. Jenner" 1105
P. Jenner Sauf Angleterre" 5
Angleterre Et P. Jenner 10
Angleterre Ou P. Jenner 1120
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
005131 P. Jenner [Royaume-Uni]Oxidative mechanisms in nigral cell death in Parkinson's disease
005C72 D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. MarsdenIncreated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
006006 Stocchi [Italie] ; S. Ruggieri [Italie] ; A. Carta [Italie] ; J. Ryatt [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. Agnoli [Italie]Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's disease
006300 Schapira [Royaume-Uni] ; I. J. Holt [Royaume-Uni] ; M. Sweeney [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Mitochondrial DNA analysis in Parkinson's disease
006422 Gibb [Royaume-Uni] ; M. Terruli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
006493 W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. MarsdenThe evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
006525 S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]The effect of carbidopa on plasma and muscle levels of L‐dopa, dopamine, and their metabolites following L‐dopa administration to rats
006631 M. Nomoto [Royaume-Uni] ; S. Stahl [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmoset
006687 M. L. De Ceballos [Royaume-Uni] ; M. Baker [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]Do enkephalins in basal ganglia mediate a physiological motor rest mechanism?
006701 J. Garvey [Royaume-Uni] ; M. Petersen ; C. M. Waters ; S. P. Rose [Royaume-Uni] ; S. Hunt ; R. Briggs ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Administration of MPTP to the common marmoset does not alter cortical cholinergic function

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024